• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞有助于急性肾小管上皮损伤的肾脏修复。

Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury.

作者信息

Herrera Maria Beatriz, Bussolati Benedetta, Bruno Stefania, Fonsato Valentina, Romanazzi Giuseppe Mauriello, Camussi Giovanni

机构信息

Cattedra di Nefrologia, Dipartimento di Medicina Interna, Università di Torino, and Centro Ricerca Medicina Sperimentale, 10126 Torino, Italy.

出版信息

Int J Mol Med. 2004 Dec;14(6):1035-41.

PMID:15547670
Abstract

Acute renal failure (ARF) is a common disease with high morbidity and mortality. Recovery from ARF is dependent on the replacement of necrotic tubular cells with functional tubular epithelium. Recent advancement in developmental biology led to the discovery of immature mesenchymal stem cells (MSCs) in bone marrow and several established organs and to the definition of their potential in the recovery from tissue injury. We investigated the effect of MSCs infusion on the recovery from ARF induced by intramuscle injection of glycerol in C57/BL6 mice. In this model, ARF is associated with an extensive necrosis of tubular epithelial cells due to myoglobin- and hemoglobin-induced injury. MSCs were obtained from bone marrow of transgenic mice expressing green fluorescent protein (GFP). MSC GFP-positive cells (MSC-GFP(+)) injected intravenously homed to the kidney of mice with glycerol-induced ARF but not to the kidney of normal mice. MSC-GFP(+) localized in the context of the tubular epithelial lining and expressed cytokeratin, indicating that MSCs engrafted in the damaged kidney, differentiated into tubular epithelial cells and promoted the recovery of morphological and functional alterations. Moreover, MSCs enhanced tubular proliferation as detected by the increased number of proliferating cell nuclear antigen (PCNA) positive cells. A significant contribution of the engrafted MSCs in the regeneration of tubular epithelial cells was shown by the presence of a consistent number of GFP(+) tubular cells 21 days after the induction of injury. In conclusion, these results indicated a tropism of MSCs for the injured kidney and a potential contribution of these cells to tubular regeneration and to the recovery from ARF.

摘要

急性肾衰竭(ARF)是一种发病率和死亡率都很高的常见疾病。ARF的恢复取决于用功能性肾小管上皮细胞替代坏死的肾小管细胞。发育生物学的最新进展导致在骨髓和几个成熟器官中发现了未成熟的间充质干细胞(MSCs),并明确了它们在组织损伤恢复中的潜力。我们研究了在C57/BL6小鼠中,静脉输注MSCs对肌肉注射甘油诱导的ARF恢复的影响。在这个模型中,ARF与肌红蛋白和血红蛋白诱导的损伤导致的肾小管上皮细胞广泛坏死有关。MSCs取自表达绿色荧光蛋白(GFP)的转基因小鼠的骨髓。静脉注射的绿色荧光蛋白阳性的MSCs(MSC-GFP(+))归巢到甘油诱导的ARF小鼠的肾脏,但不归巢到正常小鼠的肾脏。MSC-GFP(+)定位于肾小管上皮内衬,表达细胞角蛋白,表明MSCs植入受损肾脏,分化为肾小管上皮细胞,并促进形态和功能改变的恢复。此外,通过增殖细胞核抗原(PCNA)阳性细胞数量增加检测到MSCs增强了肾小管增殖。损伤诱导21天后,一致数量的GFP(+)肾小管细胞的存在表明植入的MSCs对肾小管上皮细胞再生有显著贡献。总之,这些结果表明MSCs对受损肾脏具有趋向性,并且这些细胞对肾小管再生和ARF恢复有潜在贡献。

相似文献

1
Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury.间充质干细胞有助于急性肾小管上皮损伤的肾脏修复。
Int J Mol Med. 2004 Dec;14(6):1035-41.
2
Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells.骨髓间充质干细胞通过分化为肾小管上皮样细胞改善大鼠急性肾衰竭。
Int J Mol Med. 2008 Sep;22(3):325-32.
3
Insights into the role of bone marrow-derived stem cells in renal repair.深入了解骨髓源性干细胞在肾脏修复中的作用。
Kidney Blood Press Res. 2008;31(2):104-10. doi: 10.1159/000121387. Epub 2008 Mar 20.
4
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.间充质干细胞通过分化和血管生成促进伤口愈合。
Stem Cells. 2007 Oct;25(10):2648-59. doi: 10.1634/stemcells.2007-0226. Epub 2007 Jul 5.
5
Insulin-like growth factor-1 sustains stem cell mediated renal repair.胰岛素样生长因子-1维持干细胞介导的肾脏修复。
J Am Soc Nephrol. 2007 Nov;18(11):2921-8. doi: 10.1681/ASN.2006121318. Epub 2007 Oct 17.
6
[Magnetic resonance imaging of mesenchymal stem cells transplanted intravascularly in treatment of acute renal failure:in vivo experiment with rats].血管内移植间充质干细胞治疗急性肾衰竭的磁共振成像:大鼠体内实验
Zhonghua Yi Xue Za Zhi. 2008 Jul 15;88(27):1921-4.
7
Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium.骨髓来源的细胞对再生前列腺上皮的贡献需要上皮结构破坏。
J Urol. 2006 Aug;176(2):813-8. doi: 10.1016/j.juro.2006.03.077.
8
Evidence of temporary airway epithelial repopulation and rare clonal formation by BM-derived cells following naphthalene injury in mice.小鼠萘损伤后骨髓来源细胞导致气道上皮短暂再填充及罕见克隆形成的证据。
Anat Rec (Hoboken). 2007 Sep;290(9):1033-45. doi: 10.1002/ar.20574.
9
Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.间充质干细胞中睫状神经营养因子的过表达可减少实验性自身免疫性脑脊髓炎小鼠的脱髓鞘并诱导临床恢复。
J Neuroimmunol. 2009 Jan 3;206(1-2):58-69. doi: 10.1016/j.jneuroim.2008.10.014. Epub 2008 Dec 9.
10
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.人骨髓间充质干细胞可加速小鼠急性肾损伤的恢复并延长其生存期。
Stem Cells. 2008 Aug;26(8):2075-82. doi: 10.1634/stemcells.2007-0795. Epub 2008 May 22.

引用本文的文献

1
Therapeutic application of extracellular vesicles in human diseases.细胞外囊泡在人类疾病中的治疗应用。
Mol Ther. 2025 May 7;33(5):2243-2251. doi: 10.1016/j.ymthe.2025.04.002. Epub 2025 Apr 3.
2
Targeted therapeutic strategies for the kidney.针对肾脏的靶向治疗策略。
Expert Opin Ther Targets. 2024 Nov;28(11):979-989. doi: 10.1080/14728222.2024.2421756. Epub 2024 Nov 3.
3
Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells.
急性肾损伤后尿源性干细胞在肾脏再生中的治疗潜力:与间充质干细胞的比较分析
World J Stem Cells. 2024 May 26;16(5):525-537. doi: 10.4252/wjsc.v16.i5.525.
4
The impact of bone marrow-derived mesenchymal stem cells on experimental testicular torsion in rats.骨髓间充质干细胞对大鼠实验性睾丸扭转的影响。
Turk J Med Sci. 2021 Nov 9;52(2):505-513. doi: 10.3906/sag-2105-168. eCollection 2022.
5
Cell Therapies and Gene Therapy for Diabetes: Current Progress.糖尿病的细胞疗法和基因疗法:当前进展
Curr Diabetes Rev. 2025;21(8):e130524229899. doi: 10.2174/0115733998292392240425122326.
6
Delivery of Mesenchymal Stem Cells during Hypothermic Machine Perfusion in a Translational Kidney Perfusion Study.在转化肾脏灌注研究中的低温机器灌注期间输送间充质干细胞。
Int J Mol Sci. 2024 May 5;25(9):5038. doi: 10.3390/ijms25095038.
7
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells.间充质干细胞治疗肾脏疾病的研究进展。
Curr Pharm Des. 2024;30(11):825-840. doi: 10.2174/0113816128296105240305110312.
8
Human umbilical cord/placenta mesenchymal stem cell conditioned medium attenuates intestinal fibrosis in vivo and in vitro.人脐带/胎盘间充质干细胞条件培养基减轻体内和体外的肠道纤维化。
Stem Cell Res Ther. 2024 Mar 7;15(1):69. doi: 10.1186/s13287-024-03678-4.
9
Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.间充质干细胞在糖尿病肾病中的应用:机制、信号通路和临床前证据。
Mol Cell Biochem. 2022 Aug;477(8):2073-2092. doi: 10.1007/s11010-022-04421-4. Epub 2022 Apr 25.
10
Treatment of Chronic Kidney Disease with Extracellular Vesicles from Mesenchymal Stem Cells and CD133 Expanded Cells: A Comparative Preclinical Analysis.间充质干细胞来源的细胞外囊泡和扩增 CD133 细胞治疗慢性肾脏病:一项比较性临床前分析。
Int J Mol Sci. 2022 Feb 25;23(5):2521. doi: 10.3390/ijms23052521.